Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/05/1998 | WO1998009159A1 Micro injector sample delivery system for charged molecules |
03/05/1998 | WO1998008974A2 Catalytic nucleic acid and its medical use |
03/05/1998 | WO1998008973A1 Global amplification of nucleic acids |
03/05/1998 | WO1998008972A1 Sequential hybridization of fungal cell dna and method for the detection of fungal cells in clinical material |
03/05/1998 | WO1998008971A1 Method to detect clinically relevant mutations of the dna sequence of ki -ras oncogene, its use and a testkit for early diagnosis of tumours |
03/05/1998 | WO1998008965A2 Cd95 regulatory gene sequences and transcription factors |
03/05/1998 | WO1998008964A1 Mammalian artificial chromosomes |
03/05/1998 | WO1998008963A1 Gene combinations for herbicide tolerance in corn |
03/05/1998 | WO1998008962A1 Early seed 5' regulatory sequence |
03/05/1998 | WO1998008961A2 Endosperm and nucellus specific genes, promoters and uses thereof |
03/05/1998 | WO1998008960A1 IDENTIFICATION OF AND CLONING A MOBILE TRANSPOSON FROM $i(ASPERGILLUS) |
03/05/1998 | WO1998008959A1 In vivo protein synthesis method |
03/05/1998 | WO1998008958A1 Novel expression vectors |
03/05/1998 | WO1998008957A1 Compositions and methods for specifically targeting tumors |
03/05/1998 | WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd |
03/05/1998 | WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
03/05/1998 | WO1998008954A2 Production of heme and recombinant hemoproteins |
03/05/1998 | WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
03/05/1998 | WO1998008952A1 Vaccine production of the bacillus anthracis protective antigen |
03/05/1998 | WO1998008951A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
03/05/1998 | WO1998008950A1 Novel monocyte activating cytokine |
03/05/1998 | WO1998008949A1 P-selectin ligand proteins |
03/05/1998 | WO1998008948A1 Protein targeting to glycogen |
03/05/1998 | WO1998008947A1 Enhancement of dna immunization through the use of cytokines |
03/05/1998 | WO1998008946A1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis |
03/05/1998 | WO1998008945A1 Protein inhibitor of neuronal nitric oxide synthase |
03/05/1998 | WO1998008944A1 Novel bacteriophage, method for screening the same, novel biobactericidal materials prepared with the use of the same, and reagent for detecting the same |
03/05/1998 | WO1998008943A1 Hla-drb1 peptides with specific binding affinity for hla-dq molecules: prevention and treatment of rheumatoid arthritis |
03/05/1998 | WO1998008937A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
03/05/1998 | WO1998008936A1 Recombinant canine herpesvirus |
03/05/1998 | WO1998008934A1 Serum-free mammalian cell culture medium, and uses thereof |
03/05/1998 | WO1998008933A1 Kuz, a novel family of metalloproteases |
03/05/1998 | WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
03/05/1998 | WO1998008872A1 Glp-2 derivatives |
03/05/1998 | WO1998008870A1 Interleukin-19 |
03/05/1998 | WO1998008869A1 Hematopoietic stem cell growth factor (scgf) |
03/05/1998 | WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
03/05/1998 | WO1998008863A1 Enzyme and dna sequence encoding same |
03/05/1998 | WO1998008859A1 Bioconjugates and delivery of bioactive agents |
03/05/1998 | WO1998008856A2 Mirror-symmetrical selection and evolution of nucleic acids |
03/05/1998 | WO1998008607A1 Altering dough viscoelasticity with modified glutenins |
03/05/1998 | WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
03/05/1998 | WO1998008388A1 Pesticidal agents |
03/05/1998 | WO1998008381A1 Therapeutic and diagnostic applications of perlecan domain i splice variants |
03/05/1998 | WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
03/05/1998 | WO1998004717A3 Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner |
03/05/1998 | WO1998004586A3 Polynucleotide and its use for modulating a defence response in plants |
03/05/1998 | WO1998002552A3 Vaccine compositions |
03/05/1998 | WO1998002548A3 Infectious papillomavirus pseudoviral particles |
03/05/1998 | WO1998001554A3 Secreted proteins and polynucleotides encoding them |
03/05/1998 | WO1998001553A3 Secreted proteins and polynucleotides encoding them |
03/05/1998 | WO1998001552A3 Secreted proteins and polynucleotides encoding them |
03/05/1998 | WO1998001160A3 Compositions suitable for delivery of genes to epithelial cells |
03/05/1998 | WO1998000532A3 Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth |
03/05/1998 | WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor |
03/05/1998 | WO1997040462A3 Correlating polymorphic forms with multiple phenotypes |
03/05/1998 | WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
03/05/1998 | DE19737917A1 Detection of Ki-ras oncogene alterations |
03/05/1998 | CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
03/05/1998 | CA2264576A1 Protein inhibitor of neuronal nitric oxide synthase |
03/05/1998 | CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
03/05/1998 | CA2264550A1 In vivo protein synthesis method |
03/05/1998 | CA2264548A1 Interleukin-19 |
03/05/1998 | CA2264246A1 Catalytic nucleic acid and its medical use |
03/05/1998 | CA2264244A1 Vaccine production of the bacillus anthracis protective antigen |
03/05/1998 | CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd |
03/05/1998 | CA2263897A1 Pesticidal agents |
03/05/1998 | CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections |
03/05/1998 | CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use |
03/05/1998 | CA2263824A1 Cd95 regulatory gene sequences and transcription factors |
03/05/1998 | CA2263819A1 Insecticidal protein toxins from photorhabdus |
03/05/1998 | CA2263791A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
03/05/1998 | CA2262519A1 Identification of and cloning a mobile transposon from aspergillus |
03/05/1998 | CA2259151A1 Enzyme and dna sequence encoding same |
03/05/1998 | CA2235867A1 Hematopoietic stem cell growth factor (scgf) |
03/05/1998 | CA2233228A1 Global amplification of nucleic acids |
03/05/1998 | CA2194256A1 Ikaros: a t cell pathway regulatory gene |
03/05/1998 | CA2184780A1 Methods of diagnosing and treating cancer |
03/04/1998 | EP0826780A1 Detection of nucleic acids using G-quartets |
03/04/1998 | EP0826779A1 Strand displacement amplification using boronated nucleotides |
03/04/1998 | EP0826775A1 Vector system for conditional gene expression |
03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
03/04/1998 | EP0826773A2 Process for producing trans-4-hydroxy-l-proline |
03/04/1998 | EP0826772A2 Human mucin (MUC8) |
03/04/1998 | EP0826696A1 Use of bi-and trispecific antibodies for inducing tumor immunity |
03/04/1998 | EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies |
03/04/1998 | EP0826068A1 Method for diagnosing schizophrenia |
03/04/1998 | EP0826066A1 Methods and reagents for combined pcr amplification and hybridization probing assay |
03/04/1998 | EP0826064A1 Low oxygen affinity mutant hemoglobin |
03/04/1998 | EP0826063A1 Single-vial formulations of dna/lipid complexes |
03/04/1998 | EP0826062A1 Hbv vectors and cells for producing the same |
03/04/1998 | EP0826061A2 Improvements in or relating to plant starch composition |
03/04/1998 | EP0826060A2 Embedded expression of heterologous proteins |
03/04/1998 | EP0826059A1 Apparatus and method for delivering a nucleotide into cell nuclei |
03/04/1998 | EP0826058A2 Chimeric mcp and daf proteins with cell surface localizing domain |
03/04/1998 | EP0826057A1 Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism |
03/04/1998 | EP0826056A2 Stable variant hk2 polypeptide |
03/04/1998 | EP0826055A1 New cathepsin c homolog |
03/04/1998 | EP0826054A1 Expression of glycosyltransferase in aspergillus |
03/04/1998 | EP0826053A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE |